Glucocorticoid metabolism by 11-β hydroxysteroid dehydrogenase type 2 modulates human mineralocorticoid receptor transactivation activity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 84, Issue 2-3, 2003, Pages 239-244

  Bocchi, Brigitte ^a   Fagart, Jerome ^a   Cluzeaud, Francoise ^a   Fay, Michel ^a   Rafestin Oblin, Marie Edith ^a   Farman, Nicolette ^a  

^a INSERM   (France)

Author keywords

11 Hydroxysteroid dehydrogenase; Aldosterone; Cortical collecting duct; Mineralocorticoid receptor; Mineralocorticoid selectivity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CORTICOSTERONE; GLUCOCORTICOID; MINERALOCORTICOID RECEPTOR;

ANIMAL CELL; CELL LINE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE ACTION; HORMONE METABOLISM; KIDNEY CELL; KIDNEY COLLECTING TUBULE; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PROTEIN EXPRESSION; RAT; THREE DIMENSIONAL IMAGING; TRANSACTIVATION;

RODENTIA;

EID: 0037320190     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00036-0     Document Type: Conference Paper

References (22)

1. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P.et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
2. Verrey F. Early aldosterone action: toward filling the gap between transcription and transport. Am. J. Physiol. 277:1999;F319-F327.
3. Arriza J.L., Simerly R.B., Swanson L.W., Evans R.M. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1:1988;887-900.
4. Farman N., Rafestin-Oblin M.E. Multiple aspects of mineralocorticoid selectivity. Am. J. Physiol. Renal. Physiol. 280:2001;F181-F192.
5. Edwards C.R., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., de Kloet E.R., Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 2:1988;986-989.
6. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 242:1988;583-585.
7. White P.C., Mune T., Agarwal A.K. 11 Beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18:1997;135-156.
8. Brem A.S., Morris D.J. Interactions between glucocorticoids and mineralocorticoids in the regulation of renal electrolyte transport. Mol. Cell Endocrinol. 97:1993;C1-C5.
9. Morris D.J., Souness G.W., Brem A.S., Oblin M.E. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues. Kidney Int. 57:2000;1370-1373.
10. Albiston A.L., Smith R.E., Obeyesekere V.R., Krozowski Z.S. Cloning of the 11 beta HSD type II enzyme from human kidney. Endocr. Res. 21:1995;399-409.
11. Gouilleux F., Sola B., Couette B., Richard-Foy H. Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter. Nucleic Acids Res. 19:1991;1563-1569.
12. Fagart J., Wurtz J.M., Souque A., Hellal-Levy C., Moras D., Rafestin-Oblin M.E. Antagonism in the human mineralocorticoid receptor. EMBO J. 17:1998;3317-3325.
13. Blot-Chabaud M., Laplace M., Cluzeaud F., Capurro C., Cassingena R., Vandewalle A., Farman N., Bonvalet J.P. Characteristics of a rat cortical collecting duct cell line that maintains high transepithelial resistance. Kidney Int. 50:1996;367-376.
14. Brown R.W., Chapman K.E., Kotelevtsev Y., Yau J.L., Lindsay R.S., Brett L., Leckie C., Murad P., Lyons V., Mullins J.J., Edwards C.R., Seckl J.R. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Biochem. J. 313:1996;1007-1017.
15. Kenouch S., Alfaidy N., Bonvalet J.P., Farman N. Expression of 11 beta-OHSD along the nephron of mammals and humans. Steroids. 59:1994;100-104.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
17. Hellal-Levy C., Couette B., Fagart J., Souque A., Gomez-Sanchez C., Rafestin-Oblin M. Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors. FEBS Lett. 464:1999;9-13.
18. Alfaidy N., Blot-Chabaud M., Robic D., Kenouch S., Bourbouze R., Bonvalet J.P., Farman N. Characteristics and regulation of 11 beta-hydroxysteroid dehydrogenase of proximal and distal nephron. Biochim. Biophys. Acta. 1243:1995;461-468.
19. Lombes M., Kenouch S., Souque A., Farman N., Rafestin-Oblin M.E. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase. Endocrinology. 135:1994;834-840.
20. Rupprecht R., Arriza J.L., Spengler D., Reul J.M., Evans R.M., Holsboer F., Damm K. Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol. Endocrinol. 7:1993;597-603.
21. Morineau G., Boudi A., Barka A., Gourmelen M., Degeilh F., Hardy N., al-Halnak A., Soliman H., Gosling J.P., Julien R., Brerault J.L., Boudou P., Aubert P., Villette J.M., Pruna A., Galons H., Fiet J. Radioimmunoassay of cortisone in serum, urine, and saliva to assess the status of the cortisol-cortisone shuttle. Clin. Chem. 43:1997;1397-1407.
22. Auzou G., Fagart J., Souque A., Hellal-Levy C., Wurtz J.M., Moras D., Rafestin-Oblin M.E. A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones. Mol. Pharmacol. 58:2000;684-691.